Unveiling CCL5: the master regulator of breast cancer progression and immune evasion. [PDF]
Mu J +5 more
europepmc +1 more source
Therapeutic effect of novel drug candidate, PRG-N-01, on NF2 syndrome-related tumor. [PDF]
Chung YH +16 more
europepmc +1 more source
Pan-Cancer Computational Analysis of RKIP (<i>PEBP1</i>) and LKB1 (<i>STK11</i>) Co-Expression Highlights Distinct Immunometabolic Dynamics and Therapeutic Responses Within the Tumor Microenvironment. [PDF]
Skouradaki E +5 more
europepmc +1 more source
Author Correction: Bmi-1 promotes the proliferation, migration and invasion, and inhibits cell apoptosis of human retinoblastoma cells via RKIP. [PDF]
Li Q, Fu T, Wei N, Wang Q, Zhang X.
europepmc +1 more source
From bench to bedside: Novel TGFβR1 inhibitor shows promise in neurofibromatosis treatment. [PDF]
Wang J, Bjerkvig R.
europepmc +1 more source
Beyond M1/M2: The Pivotal Role of Macrophage Metabolic Reprogramming in Chronic Bone Disease and Targeted Intervention. [PDF]
Wan Q +11 more
europepmc +1 more source
Targeting Kinase Suppressor of Ras 1 (KSR1) for Cancer Therapy. [PDF]
Moon H, Park H, Lee S, Lee S, Ro SW.
europepmc +1 more source
Circulating RKIP and pRKIP in Early-Stage Lung Cancer: Results from a Pilot Study. [PDF]
Gasparri R +7 more
europepmc +1 more source
Relationship of Signaling Pathways between RKIP Expression and the Inhibition of EMT-Inducing Transcription Factors SNAIL1/2, TWIST1/2 and ZEB1/2. [PDF]
Bustamante A +3 more
europepmc +1 more source
Canonical or non-canonical, all aspects of G protein-coupled receptor kinase 2 in heart failure. [PDF]
Kaplan A +5 more
europepmc +1 more source

